Prematurity
Poster Session 2
Mark A. Clapp, MD, MPH (he/him/his)
Massachusetts General Hospital
Boston, MA, United States
Cynthia Gyamfi-Bannerman, MD, MS (she/her/hers)
Professor and Chair
UC San Diego Health
La Jolla, CA, United States
Anjali J. Kaimal, MD (she/her/hers)
Professor and Vice Chair of Clinical Operations, Department of OBGYN
University of South Florida Morsani College of Medicine
Tampa, FL, United States
Jessica Cohen, PhD
Harvard TH Chan School of Public Health
Boston, MA, United States
Scott Lorch, MD, MSCE
Children's Hospital of Philadelphia
Philadelphia, PA, United States
Jason D. Wright, MD
Columbia University Medical Center
New York, NY, United States
Alexander Melamed, MD, MPH
Massachusetts General Hospital
Boston, MA, United States
To determine if antenatal steroid exposure among late preterm births varies based on a patient’s sociodemographic characteristics.
Study Design:
This is a cross-sectional analysis using the 2021 US natality data. The primary outcome was receipt of steroids among singleton late preterm births (34-36 weeks of gestation). The rates of steroid exposure were compared among the following sociodemographic factors: age, race, ethnicity, primary payer, and education. A multivariable logistic regression model was constructed with all the sociodemographic factors and clinical factors that were hypothesized to potentially influence clinical decision-making around steroid use, including gestational age, parity, fetal sex, chronic and pregnancy-related hypertension, and pre-existing and diabetes. Models used cluster robust standard errors based on county of birth.
Results:
In 2021, there were 279,305 singleton late preterm births, of which 17.5% were exposed to antenatal steroids. The rates of steroid exposure varied by all examined sociodemographic factors, with the largest range observed for payer (12.5% for self-pay to 20.1% for private insurance) (Table). In the multivariable model that accounted for clinical factors, there were no differences by maternal age; however, other sociodemographic factors were associated with steroid exposure (adjusted odds ratios shown in Table). Compared with White, Non-Hispanic, and privately individuals, odds of steroid exposure were lower in most other racial groups, in Hispanic individuals, and in non-commercially insurance patients. Higher levels of education were associated with higher odds of steroid exposure.
Conclusion: Despite no recommendations to consider sociodemographic factors when offering the intervention, steroid exposure among late preterm infants varied significantly by these observed factors. Additional work to understand the drivers of these differences, such as physician, hospital, or regional factors, can inform policy solutions to eliminate potential disparities.